The Japanese Ministry of Health, Labor and Welfare has also granted approval for the Reliant stent graft balloon catheter, which is used in abdominal and thoracic endovascular procedures to facilitate endograft modeling and fixation to the vessel wall.
Medtronic plans to launch the Talent thoracic stent graft and the Reliant stent graft balloon catheter in Japan after reimbursement approval.
Tony Semedo, vice president of the cardiovascular business at Medtronic, said: “Japan is a high-priority market for Medtronic. Pending the requisite regulatory and reimbursement approvals, in the years ahead, we intend to follow the Talent thoracic stent graft with many other aortic repair technologies from our extensive portfolio and pipeline to extend the option of minimally-invasive treatment to even more patients.”